Related Experiment Videos
Simple/rapid test devices for anti-HIV screening: do they come up to the mark?
R E Giles1, K R Perry, J V Parry
1Medical Devices Agency Evaluation Centre, Central Public Health Laboratory, London, United Kingdom.
Journal of Medical Virology
|August 10, 1999
Summary
Thirteen HIV antibody rapid tests were evaluated against laboratory EIAs. While most rapid tests showed good performance, some had false negatives and lower sensitivity, impacting their use in diverse healthcare settings.
Area of Science:
- Immunology
- Infectious Diseases
- Medical Diagnostics
Background:
- Human Immunodeficiency Virus (HIV) antibody detection is crucial for diagnosis.
- Simple/rapid test devices (S/RTDs) offer potential for point-of-care testing.
- Evaluating the performance of S/RTDs against established EIAs is essential.
Purpose of the Study:
- To assess the diagnostic accuracy of 13 HIV antibody S/RTDs.
- To compare S/RTD performance with commercial laboratory-based EIAs.
- To identify limitations and potential applications of S/RTDs.
Main Methods:
- Ninety-two specimens across four categories were tested using 13 S/RTDs.
- Results were compared against six commercial anti-HIV 1/2 EIAs.
- Sensitivity, specificity, and early seroconversion detection were evaluated.
Main Results:
- 11 of 13 S/RTDs correctly identified straightforward positive specimens.
- False negatives were observed with Uni-Gold HIV and SeroCard HIV.
- No S/RTD detected seroconversion earlier than EIAs; four performed similarly.
- Six S/RTDs showed lower sensitivity on low-titre specimens.
- A manufacturing defect in SeroCard HIV impacted results.
Conclusions:
- S/RTDs offer speed and reduced equipment needs but are generally less sensitive than EIAs.
- Performance variations necessitate careful selection for specific healthcare settings.
- Further evaluation is needed for optimal use in HIV diagnostics and confirmation.